AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Purple Biotech Ltd.

Foreign Filer Report Jan 8, 2020

7004_rns_2020-01-08_b9b77efa-bf4a-4cde-bdbe-0630e9f98fae.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

Press Release: Kitov Pharma Announces Closing of FameWave Acquisition false

����� ����� ��"� 2 380
KITOV PHARMA LTD
Corporation no: 520031238 10994
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 08/01/2020
www.isa.gov.il www.tase.co.il Reference: 2020-02-003621 Time of broadcast: 13:59 13:58:16

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPress Release: Kitov Pharma Announces Closing of FameWave Acquisition

pressrelease010820b_kitovpharmaDRAFT1_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 31/12/2019
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected]   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: ABZ Law Office
Address: Yad Harutzim 15 , Jerusalem 9342152 Telephone: 079-5722070 Facsimile: 079-5722206 E-mail: [email protected] 1
Israel

Talk to a Data Expert

Have a question? We'll get back to you promptly.